RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Pfizer
Celgene
GlaxoSmithKline
Avita Medical
Celgene
Celgene
Celgene
AlloVir
GlaxoSmithKline
Cellerant Therapeutics
Merck Sharp & Dohme LLC
Sanofi
Eli Lilly and Company